Concepedia

Daniel de la Nava

DD

6

Publications

334

Citations

6

H-Index

2018

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Clinica Universidad de Navarra

Navarre Institute of Health Research

Universidad de Navarra

University of California, San Francisco

Daniel de la Nava is an author at The University of Texas MD Anderson Cancer Center specializing in cell biology, medicine, and lung cancer.

ORCID

Top concepts

Publications per year

2018–2023

6

Publications

6

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 130 citations · Full text

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory

Iker Ausejo‐Mauleon, Sara Labiano, Daniel de la Nava et al. · Cancer Cell · 2023 · 88 citations · Full text

CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models

Montse Puigdelloses, Marc García-Moure, Sara Labiano et al. · Journal for ImmunoTherapy of Cancer · 2021 · 44 citations · Full text

Sirt1 protects from K‐Ras‐driven lung carcinogenesis

Luis Filipe Costa‐Machado, Roberto Martín‐Hernández, Miguel Ángel Sánchez‐Luengo et al. · EMBO Reports · 2018 · 32 citations · Full text

, , +6

Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

Virginia Laspidea, Montse Puigdelloses, Sara Labiano et al. · JCI Insight · 2022 · 22 citations · Full text

, , +20

Rows per page

1–5 of 6